image class="left" url="http://media5.picsearch.com/is?IffHNIoouNIDhdT2OeagqSYhxjn0b_lw0YxnQjzF2t0&height=248"Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical companies, like the makers of Xarelto, have a duty to make sure that their drugs are reasonably protected for use - and failure to accomplish so may possibly be grounds for compensation. Our lawyers are functioning tough to get these hurt by the drug the compensation they may be entitled to.













Whilst bleeding is actually a common complication associated with anticoagulants, it has been alleged that Xarelto is much more dangerous than classic blood thinners simply because no antidote exists to reverse its blood-thinning effects. This indicates that, inside the event of an emergency, individuals could be at danger for irreversible bleeding difficulties, which includes life-threatening internal and gastrointestinal hemorrhaging.













In the event you or possibly a loved a single suffered a severe bleeding event soon after taking Xarelto, you might have legal recourse. For a lot more data, make contact with us these days to possess your case reviewed, totally free of charge.






Compensation Possibilities













xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future medical bills, lost wages, discomfort and suffering and, in situations of death, funeral expenses. Additionally, they're seeking punitive damages, which are generally awarded to punish the defendant and deter other companies from acting similarly.






Why Are Lawsuits Getting Filed?













Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs inside the lawsuits allege significant and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.













In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:













The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.






The makers of the drug continue to market Xarelto as a safe anticoagulant option.






Doctors and health-related website staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.






Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.






Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.













Visit this page for far more data on the alleged health risks of Xarelto.






Multidistrict Litigation Trial Dates Set













The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
There are no comments on this page.
Valid XHTML :: Valid CSS: :: Powered by WikkaWiki